Invesco’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Buy |
21,957
+913
| +4% | +$18.3K | ﹤0.01% | 3210 |
|
|
2025
Q1 | $414K | Buy |
21,044
+5,972
| +40% | +$118K | ﹤0.01% | 3215 |
|
|
2024
Q4 | $339K | Buy |
15,072
+508
| +3% | +$11.4K | ﹤0.01% | 3364 |
|
|
2024
Q3 | $372K | Buy |
14,564
+264
| +2% | +$6.74K | ﹤0.01% | 3330 |
|
|
2024
Q2 | $334K | Buy |
14,300
+1,811
| +15% | +$42.3K | ﹤0.01% | 3439 |
|
|
2024
Q1 | $220K | Buy |
12,489
+1
| +0% | +$18 | ﹤0.01% | 3598 |
|
|
2023
Q4 | $173K | Sell |
12,488
-6,278
| -33% | -$86.9K | ﹤0.01% | 3581 |
|
|
2023
Q3 | $256K | Buy |
+18,766
| New | +$256K | ﹤0.01% | 3496 |
|